TrialCancer2022

A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.

Tateaki Naito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.